The incidence of endogenous Cushing's syndrome in the modern era

被引:71
作者
Wengander, Sofie [1 ]
Trimpou, Penelope [1 ,2 ]
Papakokkinou, Eleni [1 ,2 ]
Ragnarsson, Oskar [1 ,2 ]
机构
[1] Univ Gothenburg, Dept Internal Med & Clin Nutr, Inst Med, Sahlgrenska Acad, Gothenburg, Sweden
[2] Sahlgrens Univ Hosp, Dept Endocrinol, Bla Straket 5, SE-41345 Gothenburg, Sweden
关键词
Cushing's syndrome; diagnostic codes; epidemiology; incidence; prevalence; PITUITARY-ADENOMAS; DISEASE; MORTALITY; DIAGNOSIS; MORBIDITY; SURGERY;
D O I
10.1111/cen.14014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IntroductionEpidemiological studies on the incidence of Cushing's syndrome (CS) are few and most often includes only patients with the most common form, that is Cushing's disease (CD). ObjectiveTo analyse the incidence of endogenous CS in an unselected cohort of patients from western Sweden between 2002 and 2017. MethodsMedical records from patients who had received a diagnostic code for CS and adrenocortical carcinoma in the Vastra Gotaland County between 2002 and 2017 were reviewed. Eighty-two patients had been diagnosed with endogenous CS in the region during the study period and were included in this analysis. ResultsThirty-nine patients (48%) had CD, 21 (26%) had ectopic ACTH-producing tumour, 17 (21%) had a benign adrenal CS, and 5 (6%) had cortisol-producing adrenocortical carcinoma. Nine of 21 (43%) patients with ectopic CS had an ACTH-producing lung tumour, 4 had a neuroendocrine pancreas tumour, and 5 had an occult tumour. The annual incidence of endogenous CS was 3.2 cases per million/y; 1.5 for CD, 0.8 for ectopic CS, 0.7 for benign adrenal CS and 0.2 for adrenocortical carcinoma. ConclusionsApproximately three new cases of endogenous CS, per one million inhabitants, were diagnosed annually between 2002 and 2017. Compared with previous reports, proportionally more patients had ectopic CS. The reason for this is unclear although increased awareness of hypercortisolism in patients with malignant tumours in the modern era is a possible explanation.
引用
收藏
页码:263 / 270
页数:8
相关论文
共 23 条
[1]   Diagnosis and complications of Cushing's syndrome: A consensus statement [J].
Arnaldi, G ;
Angeli, A ;
Atkinson, AB ;
Bertagna, X ;
Cavagnini, F ;
Chrousos, GP ;
Fava, GA ;
Findling, JW ;
Gaillard, RC ;
Grossman, AB ;
Kola, B ;
Lacroix, A ;
Mancini, T ;
Mantero, F ;
Newell-Price, J ;
Nieman, LK ;
Sonino, N ;
Vance, ML ;
Giustina, A ;
Boscaro, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (12) :5593-5602
[2]   The incidence and prevalence of Cushing's disease may be higher than previously thought: results from a retrospective study in Iceland 1955 through 2009 [J].
Arnardottir, Steinunn ;
Sigurjonsdottir, Helga Agusta .
CLINICAL ENDOCRINOLOGY, 2011, 74 (06) :793-793
[3]   Early promising results for the endoscopic surgical treatment of Cushing's disease [J].
Berker, Mustafa ;
Isikay, Ilkay ;
Berker, Dilek ;
Bayraktar, Miyase ;
Gurlek, Alper .
NEUROSURGICAL REVIEW, 2014, 37 (01) :105-113
[4]   Mortality and morbidity in Cushing's syndrome in New Zealand [J].
Bolland, Mark J. ;
Holdaway, Ian M. ;
Berkeley, Juliet E. ;
Lim, Sarina ;
Dransfield, Will J. ;
Conaglen, John V. ;
Croxson, Michael S. ;
Gamble, Greg D. ;
Hunt, Penny J. ;
Toomath, Robyn J. .
CLINICAL ENDOCRINOLOGY, 2011, 75 (04) :436-442
[5]   Incidence of Cushing's syndrome and Cushing's disease in commercially-insured patients <65 years old in the United States [J].
Broder, Michael S. ;
Neary, Maureen P. ;
Chang, Eunice ;
Cherepanov, Dasha ;
Ludlam, William H. .
PITUITARY, 2015, 18 (03) :283-289
[6]   Mortality and Morbidity in Cushing's Disease over 50 Years in Stoke-on-Trent, UK: Audit and Meta-Analysis of Literature [J].
Clayton, R. N. ;
Raskauskiene, D. ;
Reulen, R. C. ;
Jones, P. W. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (03) :632-642
[7]   Mortality in patients treated for Cushing's disease is increased, compared with patients treated for nonfunctioning pituitary macroadenoma [J].
Dekkers, O. M. ;
Biermasz, N. R. ;
Pereira, A. M. ;
Roelfsema, F. ;
van Aken, M. O. ;
Voormolen, J. H. C. ;
Romijn, J. A. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (03) :976-981
[8]   Long-term remission and recurrence rates after first and second transsphenoidal surgery for Cushing's disease: care reality in the Munich Metropolitan Region [J].
Dimopoulou, C. ;
Schopohl, J. ;
Rachinger, W. ;
Buchfelder, M. ;
Honegger, J. ;
Reincke, M. ;
Stalla, G. K. .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2014, 170 (02) :283-292
[9]   MORBIDITY AND MORTALITY IN CUSHINGS-DISEASE - AN EPIDEMIOLOGIC APPROACH [J].
ETXABE, J ;
VAZQUEZ, JA .
CLINICAL ENDOCRINOLOGY, 1994, 40 (04) :479-484
[10]   Transsphenoidal microsurgery for Cushing's disease: Initial outcome and long-term results [J].
Hammer, GD ;
Tyrrell, JB ;
Lamborn, KR ;
Applebury, CB ;
Hannegan, ET ;
Bell, S ;
Rahl, R ;
Lu, A ;
Wilson, CB .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (12) :6348-6357